Primary updates to the guidance includes the composition of the 2020-2021 flu vaccines and the recent licensures of 2 new influenza vaccines.
The Advisory Committee on Immunization Practices (ACIP) updated its seasonal flu vaccine guidance for the 2020-2021 influenza season.
With flu season approaching, pharmacies are gearing up for a busy season as the coronavirus disease 2019 (COVID-19) continues to circulate. Prevention of and reduction in the severity of influenza illnesses and reduction of outpatient illnesses, hospitalizations, and intensive care unit admission is especially important to alleviate stress on the US health care system during the pandemic.
According to ACIP, primary updates and changes to the recommendations include the vaccine virus composition for 2020-2021 US seasonal influenza vaccines and recent regulatory actions, including 2 new influenza vaccine licensures.
In general, routine annual influenza vaccination of all individuals aged 6 months and older who do not have contraindications continues to be recommended. No preferential recommendations is made for 1 influenza vaccine product over another for individuals for whom more than 1 licensed, recommended, and appropriate product is available.
The composition of the 2020-2021 US influenza vaccine includes updates to the influenza A(H1N1)pdm09, influenza A(H3N2), and influenza B/Victoria lineage components. The following influenza vaccines will be available for this season:
Two new influenza vaccine licensures are described in the updated guidance:
Additional changes include:
Read the full report for more information.
Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices–United States, 2020-21 influenza season. Morbidity and Mortality Weekly Report. 2020. Doi: http://dx.doi.org/10.15585/mmwr.rr6908a1external icon